Here's what you think

Here's what you think More than 250 readers completed our online survey about framing science. The Readers and Editors of The Scientist ARTICLE EXTRAS The Future of Public Engagement Results of Our Online Survey A Typology of Frames Specific to Science-Related Issues How To Start? Our Reader's Thoughts On average, most of the practicing, former, and non-scientists who completed our online poll about framing agree with the principle t

Written byThe Readers and Editors of The Scientist
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Readers and Editors of The Scientist

The Future of Public Engagement

Results of Our Online Survey

A Typology of Frames Specific to Science-Related Issues

How To Start?

Our Reader's Thoughts

On average, most of the practicing, former, and non-scientists who completed our online poll about framing agree with the principle that scientists should accommodate their message to suit their audience.

The majority of all groups also believed that scientists should publicly discuss the ethical and policy aspects of their work, and technical accuracy is not the most important part of public communication. Currently, scientists are not getting their messages across, they said: Roughly 60% of readers disagreed with the statement that "scientists do a good job of communicating complex technical issues to the public." This is a problem organizations should help solve, you said: The majority of all groups agreed that science graduate programs, scientific organizations, and government funding ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies